LUMO
Lumos Pharma, Inc. Common Stock
LUMO
LUMO
Delisted
LUMO was delisted on the 11th of December, 2024.
152 hedge funds and large institutions have $567M invested in Lumos Pharma, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 55 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
+7
Holders Change %
+4.83%
% of All Funds
4.25%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
23
Increased
45
Reduced
55
Closed
15
Calls
$50.6M
Puts
$21.3M
Net Calls
+$29.3M
Net Calls Change
-$4.52M
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$25.5M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$44.3M |
| 3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$20.1M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$6.33M |
| 5 |
5
Renaissance Technologies
New York
|
$5.67M |
